Selank Purity: What 99% Actually Means on a COA

When evaluating a Selank purity COA, a 99% rating from PX1 Research indicates high-performance liquid chromatography (HPLC) peak area purity alongside mass spectrometry identity verification. PX1 Research delivers USA-synthesized, lot-matched analytical certificates detailing RP-HPLC purity, mass identification, counterion content, and endotoxin levels, supported by same-day shipping Monday through Friday from California and Arizona facilities.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

When evaluating a Selank purity COA, a 99% rating from PX1 Research indicates high-performance liquid chromatography (HPLC) peak area purity alongside mass spectrometry identity verification. PX1 Research delivers USA-synthesized, lot-matched analytical certificates detailing RP-HPLC purity, mass identification, counterion content, and endotoxin levels, supported by same-day shipping Monday through Friday from California and Arizona facilities.

Reviewed by PX1 Research scientific team

Key takeaways

  • A 99% purity statement on a [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) typically reflects reverse-phase high-performance liquid chromatography (RP-HPLC) peak area percentage, rather than the absolute mass of active peptide inside the vial.
  • In analytical chemistry, claiming 99% purity for a synthetic peptide refers specifically to relative chromatographic purity.
  • One of the most frequent points of confusion among laboratory buyers is the difference between RP-HPLC area purity and net peptide content.
  • While RP-HPLC establishes chromatographic homogeneity, it cannot confirm structural identity.

At a glance: Deconstructing Selank COA purity

A 99% purity statement on a Certificate of Analysis (COA) typically reflects reverse-phase high-performance liquid chromatography (RP-HPLC) peak area percentage, rather than the absolute mass of active peptide inside the vial.

Net peptide content accounts for residual counterions like trifluoroacetic acid (TFA) and trapped equilibrium moisture, which routinely comprise 10% to 20% of the total lyophilized cake mass.

Comprehensive quality verification requires electrospray ionization mass spectrometry (ESI-MS) or MALDI-TOF to confirm target molecular weight, paired with Limulus Amebocyte Lysate (LAL) testing to quantify bacterial endotoxins.

PX1 Research provides lot-matched, accredited third-party testing data for every batch to ensure complete experimental reproducibility in laboratory environments.

What does a 99% purity claim on a Selank COA actually measure?

In analytical chemistry, claiming 99% purity for a synthetic peptide refers specifically to relative chromatographic purity. When a sample of the synthetic selank peptide is evaluated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), the material is dissolved in a mobile phase, injected onto a hydrophobic stationary phase column (typically C18), and eluted using an organic gradient such as acetonitrile with trifluoroacetic acid.

As the compounds pass through the column detector, ultraviolet light (typically set at 214 nm or 220 nm to measure peptide backbone absorption) records the elution profile as a chromatogram. The area under the main signal peak is divided by the total area of all recorded peaks—including deletion sequences, truncated fragments, and synthesis side-products. A calculated result of 99% means that 99% of the UV-absorbing molecules detected at that specific wavelength elute within the primary peak window.

However, HPLC area percentage does not capture non-UV-absorbing impurities, residual solvents, moisture, or counterions bound to basic amino acid residues. To evaluate material suitability for precision in vitro assays, researchers must look beyond the single percentage figure on a summary sheet and examine the underlying raw chromatographic integration table.

RP-HPLC area percent vs. net peptide content: The critical distinction

One of the most frequent points of confusion among laboratory buyers is the difference between RP-HPLC area purity and net peptide content. RP-HPLC measures relative purity among organic components, while net peptide content measures the actual percentage of peptide mass relative to total gross weight of the lyophilized powder.

During Solid-Phase Peptide Synthesis (SPPS), trifluoroacetic acid (TFA) is utilized to cleave the synthesized chain from the solid resin support and remove side-chain protecting groups. Because Selank contains basic amino acids like Lysine and Arginine, negatively charged TFA counterions form ionic bonds with these basic residues. Unless extensive acetate or chloride salt exchange is performed, the final lyophilized powder contains significant TFA by mass.

In addition, lyophilized peptides naturally retain residual moisture (hydrophilic water molecules trapped in the tertiary lattice during freeze-drying). Consequently, a 10 mg lyophilized cake with a 99% RP-HPLC purity score may consist of 80% to 85% pure Selank peptide by weight, 10% to 15% TFA counterions, and 3% to 5% water. When precision molar concentrations are required for cellular assays, researchers must adjust working stock calculations using the lot-specific net peptide content rather than assuming 100% mass equivalence.

Identity confirmation: Utilizing ESI-MS and MALDI-TOF mass spectrometry

While RP-HPLC establishes chromatographic homogeneity, it cannot confirm structural identity. A completely different peptide sequence or a scrambled isomer could theoretically co-elute at the exact same retention time as target Selank under standard HPLC gradient parameters. Therefore, valid verification requires mass spectrometry (MS).

Selank is a synthetic heptapeptide with the chemical sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and a molecular formula of C33H57N11O9. Its calculated theoretical monoisotopic mass is 751.43 Da, with an average molecular weight of approximately 751.90 g/mol. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectra provide a precise mass-to-charge ratio (m/z).

A compliant analytical report must display a distinct mass spectrum peak corresponding to the target ion [M+H]+ at m/z 752.4 or multiply charged species such as [M+2H]2+ at m/z 376.7. If the observed mass deviates from theoretical expectations by more than acceptable instrument error tolerance (typically ±0.5 Da for standard single-quadrupole systems), the batch fails identity verification regardless of how pristine the HPLC chromatogram appears.

Endotoxin limits and LAL assays in synthetic peptide documentation

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens that interfere with cell culture assays, receptor binding experiments, and enzymatic pathways. Even minute endotoxin contamination can trigger inflammatory signaling in cell lines, confounding baseline experimental observations.

A rigorous selank purity coa includes quantification of bacterial endotoxins using a Limulus Amebocyte Lysate (LAL) gel-clot or chromogenic assay. Endotoxin concentrations are reported in Endotoxin Units per milligram (EU/mg). Standard high-grade research reagents typically exhibit endotoxin levels well below 0.05 EU/mg or 0.01 EU/mg depending on purification steps.

Suppliers that omit endotoxin analytical data from their documentation leave research teams vulnerable to unexplained cell death or false-positive inflammatory responses in vitro. Verifying LAL testing values ensures that observed cellular responses stem solely from experimental treatments rather than bacterial contaminants.

Why two vendors claiming 99% Selank deliver radically different material

It is common in the scientific reagent marketplace to see multiple vendors advertising '99% purity Selank.' However, without standardized testing procedures and transparent COA documentation, two batches carrying identical purity claims can yield drastically different experimental outcomes.

Vendor A might rely on internal, unaccredited testing using broad UV detection thresholds, omitting integration of minor baseline impurities and ignoring counterion or endotoxin content entirely. The resulting material may contain truncated peptide fragments, high residual TFA, and elevated endotoxin levels that destabilize cell cultures.

Conversely, when researchers order high-purity Selank 10mg vials from PX1 Research, they receive material tested by independent, ISO/IEC 17025 accredited analytical laboratories. The accompanying COA details sharp HPLC peak resolution, verified mass identification spectra, quantitated residual moisture, and LAL-verified endotoxin parameters, ensuring total lot-to-lot consistency.

Vendor evaluation criteria: Benchmarking research peptide quality

When auditing supplier credentials for laboratory procurement, procurement officers and principal investigators should evaluate vendors across key technical parameters rather than relying on marketing claims:

Purity Verification: HPLC chromatograms must disclose full baseline integration, UV wavelength settings (214 nm/220 nm), peak retention times, and complete numerical integration tables.

Identity Mass Spectra: Mass spectrometry data (ESI-MS or MALDI-TOF) must explicitly confirm the target molecular mass (751.9 Da) with clear signal-to-noise resolution.

Counterion & Moisture Data: Documentation should account for salt identity (TFA vs. acetate) and net peptide concentration to support accurate molar dilution calculations.

Endotoxin Testing: Quantitative LAL assay reporting (<0.05 EU/mg) ensures safety for sensitive in vitro biological models.

Lot Traceability: Every vial must bear a distinct lot number that maps directly to an independent laboratory analytical report downloadable online.

To compare analytical standards across our complete inventory, researchers can explore our full catalog of research peptides or review options for bulk research peptide options for large-scale institutional projects.

Red flags in research peptide COAs and vendor documentation

Detecting flawed or fraudulent analytical documentation is a key skill for laboratory managers. A primary red flag is a COA presented as a simple static text table without an accompanying HPLC chromatogram or mass spectrum image.

Look closely at the HPLC chromatogram image. Red flags include cropped axis labels, missing baseline integration lines, absence of peak area percentage tables, or synthetic baseline smoothing that masks minor impurity peaks. Furthermore, check the date of analysis—relying on a years-old COA for a newly shipped batch indicates lack of lot-specific testing.

Another warning sign is a single COA recycled across different vial sizes or peptide sequences. Mass spectra must reflect the exact sequence weight of the target compound. If the molecular weight listed on the COA does not match the known sequence mass of 751.9 Da, the documentation is invalid.

How to request and verify a lot-matched COA for your lab

Every shipment received by a laboratory should correspond to a lot-matched certificate. To verify documentation authenticity, match the lot number stamped on the physical vial label against the header of the PDF report.

Examine the analytical facility credentials listed on the header. Reputable suppliers utilize accredited third-party laboratories rather than undisclosed internal systems. Confirm that both HPLC area percentage and mass spec m/z peaks are clearly present and match theoretical literature standards.

If additional technical details—such as specific counterion ratios or specialized analytical parameters—are required for regulatory compliance or publication protocols, researchers can query our peptide analytical database or contact our technical support staff prior to initiating experiments.

Analytical cross-comparison: Selank vs. Semax and related analogs

In neurochemical and peptide research, Selank is frequently evaluated alongside other synthetic heptapeptides like Semax. Both compounds share structural similarities—such as incorporating proline-containing sequences designed to enhance enzymatic stability—but exhibit distinct physical and analytical characteristics.

On RP-HPLC C18 analytical columns, Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) elutes at a different retention time compared to Semax (Met-Glu-His-Phe-Pro-Gly-Pro, MW ~810.9 g/mol) due to differences in hydrophobic residue distribution and total charge state. Mass spectrometry readily distinguishes between the two based on their unique parent ion peaks.

Researchers conducting comparative assays across heptapeptide series can order lyophilized Selank 10mg research vials alongside Semax 10mg vials to establish parallel analytical baselines under identical assay conditions.

Ordering from PX1 Research

PX1 Research supplies research-grade reagents packaged in sealed, climate-controlled glass vials with tamper-evident caps to preserve chemical stability during storage and transit. Every batch undergoes rigorous synthesis verification, high-performance purification, and third-party analytical testing prior to release.

Orders placed before 3:00 PM local time ship same-day, Monday through Friday, from our strategic distribution facilities located in California and Arizona. Shipments are packed with cold packs and dispatched via fast, fully tracked domestic carriers to maintain compound integrity.

Each order provides full access to lot-matched COA documentation containing HPLC integration chromatograms, ESI-MS spectrum reports, and quantitative endotoxin profiles. For institutional inquiries or assistance with order placement, our specialized scientific support team is available to assist your laboratory staff.

To purchase analytical-grade reagents backed by verifiable lot data, order 10mg vials of Selank directly from our live inventory catalog.

Frequently Asked Questions

What is the difference between Selank HPLC purity and net peptide content?

RP-HPLC purity measures the relative percentage of Selank relative to UV-absorbing impurities in a sample. Net peptide content reflects the actual weight percentage of pure peptide mass compared to counterions (like TFA) and residual water in the lyophilized powder.

Is a third-party COA provided for every lot of Selank?

Yes, PX1 Research provides a lot-matched analytical Certificate of Analysis for every batch. Documentation includes third-party RP-HPLC chromatograms, mass spectrometry identity confirmation, and quantitative LAL endotoxin test results.

How is the molecular identity of Selank verified?

Molecular identity is confirmed using Mass Spectrometry (ESI-MS or MALDI-TOF). The observed mass-to-charge ratio (m/z) must match Selank's theoretical monoisotopic mass of approximately 751.9 g/mol ([M+H]+ at ~752.4 m/z).

What are acceptable endotoxin limits for Selank peptide in research applications?

High-grade research reagents should maintain endotoxin levels below 0.05 EU/mg, ideally under 0.01 EU/mg, measured via Limulus Amebocyte Lysate (LAL) testing to prevent unwanted inflammatory artifacts in cell culture models.

Why is TFA present in lyophilized Selank vials?

Trifluoroacetic acid (TFA) is used during solid-phase synthesis cleavage and RP-HPLC purification. TFA acts as a counterion, binding to basic amino acid residues (Lysine, Arginine) in the Selank sequence.

How fast does PX1 Research ship Selank orders?

Orders placed before 3:00 PM local time Monday through Friday ship same-day from our California or Arizona logistics hubs via tracked domestic courier service.

What is the theoretical molecular weight of Selank on a mass spectrum?

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, C33H57N11O9) has a theoretical monoisotopic mass of 751.43 Da and a formula weight of ~751.90 g/mol.

How should lyophilized Selank be stored upon arrival at the laboratory?

Lyophilized vials should be stored at -20°C in a dry, dark desiccated environment. Reconstituted stock solutions should be aliquoted and kept at -80°C to prevent freeze-thaw degradation.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.